1. Home
  2. SLS vs OPBK Comparison

SLS vs OPBK Comparison

Compare SLS & OPBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLS
  • OPBK
  • Stock Information
  • Founded
  • SLS 2012
  • OPBK 2005
  • Country
  • SLS United States
  • OPBK United States
  • Employees
  • SLS N/A
  • OPBK N/A
  • Industry
  • SLS Biotechnology: Pharmaceutical Preparations
  • OPBK Major Banks
  • Sector
  • SLS Health Care
  • OPBK Finance
  • Exchange
  • SLS Nasdaq
  • OPBK Nasdaq
  • Market Cap
  • SLS 185.3M
  • OPBK 204.6M
  • IPO Year
  • SLS N/A
  • OPBK 2018
  • Fundamental
  • Price
  • SLS $1.69
  • OPBK $14.21
  • Analyst Decision
  • SLS Strong Buy
  • OPBK Hold
  • Analyst Count
  • SLS 1
  • OPBK 1
  • Target Price
  • SLS $7.00
  • OPBK $15.50
  • AVG Volume (30 Days)
  • SLS 2.0M
  • OPBK 36.8K
  • Earning Date
  • SLS 11-12-2025
  • OPBK 10-23-2025
  • Dividend Yield
  • SLS N/A
  • OPBK 3.36%
  • EPS Growth
  • SLS N/A
  • OPBK 8.15
  • EPS
  • SLS N/A
  • OPBK 1.48
  • Revenue
  • SLS N/A
  • OPBK $84,078,000.00
  • Revenue This Year
  • SLS N/A
  • OPBK $22.05
  • Revenue Next Year
  • SLS N/A
  • OPBK $10.50
  • P/E Ratio
  • SLS N/A
  • OPBK $9.65
  • Revenue Growth
  • SLS N/A
  • OPBK 9.17
  • 52 Week Low
  • SLS $0.77
  • OPBK $10.43
  • 52 Week High
  • SLS $2.27
  • OPBK $18.57
  • Technical
  • Relative Strength Index (RSI)
  • SLS 42.73
  • OPBK 52.26
  • Support Level
  • SLS $1.65
  • OPBK $14.20
  • Resistance Level
  • SLS $2.01
  • OPBK $14.73
  • Average True Range (ATR)
  • SLS 0.11
  • OPBK 0.33
  • MACD
  • SLS -0.02
  • OPBK -0.05
  • Stochastic Oscillator
  • SLS 11.11
  • OPBK 13.92

About SLS SELLAS Life Sciences Group Inc.

SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.

About OPBK OP Bancorp

OP Bancorp is engaged in the general commercial banking business in Los Angeles, Orange, and Santa Clara Counties, California, Carrollton, Texas, and Las Vegas, Nevada. The Bank is focused on serving the banking needs of small- and medium-sized businesses, professionals, and residents with a particular emphasis on Korean and other ethnic minority communities. It operates with eleven full branches.

Share on Social Networks: